Global HEOR & HTA Strategy Lead – Immunology (M/F/D)
Tasks:
Development of Global Economic models in partnership with UK, external vendor and including preparation for NICE scientific advice
Update of Global Economic model based on FIR for inclusion in the HTA submission package
ITC feasibility assessment and ITC strategy and execution for inclusion in the HTA submission package
Partnering with clients IEP squad to co-lead IEP and generate evidence relevant for HTA submissions
Development of HEOR publication plan
HEOR Ianalumab SjD Lead responsibilities, cross-functional team and country interaction
Qualification:
5+ years of relevant HEOR-related experience
8+ years of pharmaceutical industry experience
Advanced Degree; preferably Ph.D., M.D., MBA, RPh or equivalent
Fluency in English (oral and written)
Expertise in HEOR and value demonstration
Customer and patient-centric mindset
Deep understanding of payer/HTA evidence requirements and decision-making dynamics ex-US
Significant experience in global or above-country multidisciplinary drug development
Experience working with product teams
Proven track record influencing CDPs/IEPs to meet payer/HC decision-maker needs
Ability to drive multiple product-specific and enterprise-driven initiatives
Strong knowledge of research methodology and statistical methods in data analysis
Experience collaborating with quantitative scientists and analysts
Impact-oriented, enterprise and agile mindset with a proven track record of fostering innovation
Strong process and project management skills
Requirements:
Start: 07.07.2025
Duration: 6 months
Capacity: 5 days per week
Location: Basel, Switzerland